Suicide-related pediatric ED visits rose 74% from 2016 to 2022; about half occurred at EDs with lower pediatric volume, a national analysis found.
|Articles|July 1, 2000
Malpractice and emergency care: Doing right by the patient--and yourself
Providing emergency care to children is a special challenge with risks for both patient and pediatrician. Attention to some basic precautions promotes good medical care for the child and heads off legal problems for the physician at the same time.
Advertisement
Advertisement
Related to this article
Nine societies outline 6 domains of hospital-level sepsis strategies, from rapid blood culture diagnostics to daily toothbrushing protocols.
Researchers found that childhood unpredictability provided additional information about mental health risk beyond conventional ACEs screening.
Lavengratinib increased annualized height velocity in 7 children with achondroplasia, but open-label phase 2 findings remain preliminary.
The FDA granted satralizumab priority review for MOGAD after phase 3 findings showed a 68% reduction in relapse risk versus placebo.
Amélie Lothe, PhD, discusses findings showing early, sustained benefits of fenfluramine treatment for patients with Lennox-Gastaut syndrome.
FDA approved levacetylleucine (Aqneursa) for ataxia in ataxia-telangiectasia, the first therapy for the disease, in patients 15 kg or heavier.
Tallie Z. Baram, MD, talks about how adding a measure of childhood unpredictability to ACEs screening may help pediatricians identify children at risk for mental health problems.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Suicide-related emergency department visits in US children rose 74% from 2016 to 2022
2
Fenfluramine shows sustained seizure reduction, functional improvement in Lennox-Gastaut syndrome
3
Lavengratinib shows early growth signal in phase 2 achondroplasia study
4
Satralizumab for MOGAD gains FDA priority review after phase 3 relapse reduction
5